Optimizing Radiotherapy With Immunotherapy in Lung Cancer Treatment

Video

This video examines how the use of radiation therapy in patients on immunotherapy can trigger immunogenic cell death, and reviews some of the challenges related to unwanted immune responses from radiotherapy.

Several reports have described how the use of radiation therapy in patients on immunotherapy can trigger immunogenic cell death.

In this video, Ramesh Rengan, MD, PhD, of the University of Washington in Seattle, highlights research aiming to optimize this combination of radiation therapy and immunotherapy, and discusses unwanted immune responses from radiotherapy and the challenge of utilizing this combination in patients with brain metastases.

Rengan gave a presentation on this topic at the 2017 Multidisciplinary Thoracic Cancers Symposium.

Related Videos
David Porter, MD
Judy Lieberman, MD, PhD, the endowed chair in cellular and molecular medicine at Boston Children’s Hospital
Alexandra Gomez Arteaga, MD
Paul Harmatz, MD
Mark Walters, MD
Mitchel Horwitz, MD
Bruce Cree, MD, PhD, MAS, a professor of neurology and the clinical research director of the University of California San Francisco (UCSF) Multiple Sclerosis Center
Emilie Aschenbrenner, PharmD, BCOP, a hematology coordinator for pharmacy at Froedtert and the Medical College of Wisconsin
Raj Chovatiya, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.